» Articles » PMID: 26687853

Recent Advances and Future Progress in PET Instrumentation

Overview
Journal Semin Nucl Med
Specialty Nuclear Medicine
Date 2015 Dec 22
PMID 26687853
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

PET is an important and growing imaging modality. PET instrumentation has undergone a steady evolution improving various aspects of imaging. In this review, we discuss recent and future software and hardware technologies for PET/CT. The improvements include new hardware, incorporating designs with digital photomultipliers, and fast electronics, allowing implementation of time-of-flight reconstruction. Manufacturers also improved PET sensitivity with a larger axial field of view and 3D imaging. On the CT side, faster scanners and multislice detectors allow implementation of advanced acquisition protocols such as 4D CT and coronary CT angiography. Significant advances have been also made in the reconstruction software, now integrating resolution recovery with advanced iterative techniques. New PET acquisition protocols have been enabled to include continuous bed motion. Efforts have been undertaken to compensate PET scans for respiratory and also for cardiac patient motion (for cardiac imaging) during PET imaging, which significantly improves overall image quality and resolution. Finally, simultaneous PET/MR systems have been recently deployed clinically and now offer even greater potential of image quality and enhanced clinical utility. PET/MR imaging allows for perfectly registered attenuation maps, clinically important complementary MR information, and potentially superior motion correction. These recent multifaceted advances allow PET to remain as one of the most exciting and relevant imaging technologies.

Citing Articles

Joint EANM-SNMMI guideline on the role of 2-[F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).

Vaz S, Pilkington Woll J, Cardoso F, Groheux D, Cook G, Ulaner G Eur J Nucl Med Mol Imaging. 2024; 51(9):2706-2732.

PMID: 38740576 PMC: 11224102. DOI: 10.1007/s00259-024-06696-9.


Impact of simulated reduced injected dose on the assessment of amyloid PET scans.

Young P, Heeman F, Axelsson J, Collij L, Hitzel A, Sanaat A Eur J Nucl Med Mol Imaging. 2023; 51(3):734-748.

PMID: 37897616 PMC: 10796642. DOI: 10.1007/s00259-023-06481-0.


Optimization of the Acquisition Time and Injected Dose of F-Fluorodeoxyglucose Based on Patient Specifications for High-Sensitive Positron Emission Tomography/Computed Tomography Scanner.

Al-Fatlawi M, Pak F, Farzanefar S, Salehi Y, Monsef A, Sheikhzadeh P World J Nucl Med. 2023; 22(3):196-202.

PMID: 37854082 PMC: 10581753. DOI: 10.1055/s-0043-1771284.


Auto-segmentation of head and neck tumors in positron emission tomography images using non-local means and morphological frameworks.

Heydarheydari S, Tahmasebi Birgani M, Rezaeijo S Pol J Radiol. 2023; 88:e365-e370.

PMID: 37701174 PMC: 10493858. DOI: 10.5114/pjr.2023.130815.


Incidental findings on FDG-PET/CT in large vessel vasculitis.

Hans V, Abele J, Yacyshyn E Clin Rheumatol. 2023; 42(8):2163-2171.

PMID: 37086310 DOI: 10.1007/s10067-023-06558-z.